Alkermes to Take Part in the Stifel Virtual Healthcare Conference

Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) will participate in a fireside chat at the Stifel Virtual Healthcare Conference on November 16, 2021, at 9:20 a.m. ET. Investors can access the presentation via the Investors tab on the company's website. Alkermes focuses on developing innovative medicines in neuroscience and oncology, with a range of products targeting addiction, schizophrenia, and bipolar I disorder. The company has R&D facilities in Massachusetts and manufacturing sites in Ireland and Ohio.

Positive

• Participation in the Stifel Virtual Healthcare Conference could enhance investor engagement.
• Alkermes has a diverse portfolio of proprietary commercial products and a strong pipeline in neurodegenerative disorders and cancer.

Negative

• None.

News Market Reaction – ALKS

-0.56%

-0.56% Session move

In the trading session that priced this news, ALKS declined 0.56%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DUBLIN, Nov. 9, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Stifel Virtual Healthcare Conference on Tuesday, Nov. 16, 2021 at 9:20 a.m. ET (2:20 p.m. GMT). The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com. 

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-take-part-in-the-stifel-virtual-healthcare-conference-301420297.html

SOURCE Alkermes plc

FAQ

What event will Alkermes participate in on November 16, 2021?

Alkermes will participate in the Stifel Virtual Healthcare Conference.

What time is Alkermes' presentation at the Stifel Virtual Healthcare Conference?

Alkermes' presentation is scheduled for 9:20 a.m. ET on November 16, 2021.

How can investors access Alkermes' presentation during the conference?

Investors can access the presentation under the Investors tab on Alkermes' website.

What areas does Alkermes focus on in its product development?

Alkermes develops products primarily in the fields of neuroscience and oncology.